Dr. Rosol has 25 years of experience in preclinical and clinical research, trial design, operations, and regulatory execution. Most recently, he served as Chief Executive Officer of Atherion Bioresearch, a Contract Research Organization specializing in the radiopharmaceutical and radiotherapeutics space. Prior to this, he was Chief Medical Officer and Senior Vice President at Navidea Biopharmaceuticals, where he led the company’s clinical research and development programs. Before these roles, Dr. Rosol worked at Novartis Pharmaceuticals, leading key biomarker development and translational imaging groups.
Dr. Rosol holds a Ph.D. from the Boston University School of Medicine and has held various academic appointments at Harvard Medical School/Massachusetts General Hospital, the Mayo Clinic, Children’s Hospital of Los Angeles/USC Keck School of Medicine, and the Medical University of South Carolina.